NHGRI source snapshot
2020 State Bills Louisiana 2020 HB 408
Louisiana
Retrieved from NHGRI
NHGRI summary
Requires coverage of cancer treatment targeting a specific genetic mutation. Prohibits a health coverage plan from denying coverage for a medically necessary drug on the basis that the drug is not indicated for the location in the body of the patient's cancer, if the drug is FDA approved for the treatment of the specific mutation of the patient's cancer. Died.
Source links
Provenance
Courtesy: National Human Genome Research Institute. This source layer preserves the state, primary link, topic, bill status, and summary retrieved from NHGRI.